Ligand Pharmaceuticals | LGND - Ordinary Share Capital


Ligand Pharmaceuticals reported $20K in Ordinary Share Capital for its fiscal quarter ending in March of 2025.





Ordinary Share Capital Change Date
Amgen USD 538M 300K Sep/2025
Arrowhead Research USD 135.7M 2.44M Sep/2025
Baxter International USD 683M 0 Dec/2024
Bristol-Myers Squibb USD 2.04B 1.74B Sep/2025
Eli Lilly USD 946.83M 354.23M Jun/2025
Gilead Sciences USD 1.24B 0 Sep/2025
GlaxoSmithKline GBP 4.03B 119.13M Sep/2025
Glaxosmithkline GBP 4.03B 2.68B Sep/2025
Insmed USD 212.58M 210.76M Sep/2025
Ionis Pharmaceuticals USD 161.14M 160.98M Sep/2025
Ligand Pharmaceuticals USD 20K 0 Mar/2025
MacroGenics USD 63.26M 62.63M Sep/2025
Merck USD 2.49B 15.79M Sep/2025
Pacira USD 44.9M 44.85M Jun/2025
Pfizer USD 5.69B 1000K Sep/2025
Veracyte USD 78.67M 73K Sep/2025